Here are seven important trends:
1. The global orthobiologics market is projected to reach a $7.9 billion value by 2019.
2. It was valued at $5.7 billion in 2014.
3. It is estimated to grow at a compound annual growth rate of 6.7 percent from 2014 to 2019.
4. The orthobiologics market has seen rapid growth since 2012, due to increased research and development activities and a rising demand for orthobiologics products.
5. North America contributes the largest market share.
6. But, Asia is the fastest growing region in the global orthobiologics market.
7. Key players in the market include Biomet, Medtronic, Integra Life Sciences, Stryker, Zimmer, DePuy Synthes and Tornier.
More articles on devices:
10 key notes on DJO Global’s Q1 net sales — Net sales down 0.9%
OMNI Orthopaedics gets $6M financing: 5 things to know
Top 3 cities for pharmaceutical payments to physicians
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
